{
  "ticker": "JNJ",
  "target_date": "2025-04-08",
  "actual_date": "2025-04-08",
  "collected_at": "2025-12-08T11:36:52.680615",
  "price": {
    "open": 150.22,
    "high": 150.22,
    "low": 144.75,
    "close": 146.7097930908203,
    "volume": 12018400,
    "change_1d_pct": -0.41,
    "change_7d_pct": -8.37,
    "change_30d_pct": -9.69
  },
  "technicals": {
    "rsi_14": 32.47,
    "sma_20": 156.8,
    "sma_50": 155.75,
    "macd": -2.015,
    "macd_signal": -0.351,
    "macd_histogram": -1.663,
    "bb_upper": 166.36,
    "bb_lower": 147.24,
    "price_vs_sma20_pct": -6.44,
    "price_vs_sma50_pct": -5.8,
    "volume_ratio": 1.17
  },
  "fundamentals": {
    "market_cap": 489113878528,
    "pe_ratio": 19.595676,
    "forward_pe": 19.151999,
    "price_to_book": 6.161751,
    "price_to_sales": 5.307859,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.31,
    "pct_from_52w_low": 44.31
  },
  "macro": {
    "spy": {
      "price": 493.65,
      "change_1d_pct": -1.57,
      "change_7d_pct": -11.25
    },
    "treasury_10y": {
      "yield_pct": 4.26
    },
    "dollar_index": {
      "level": 102.96
    },
    "gold": {
      "price": 2968.4
    }
  },
  "news": [
    {
      "headline": "Johnson & Johnson (JNJ): Among Defensive Stocks Billionaire Ken Fisher is Betting On",
      "source": "Yahoo",
      "datetime": 1744150456,
      "summary": "We recently published a list of 10 Defensive Stocks Billionaire Ken Fisher is Betting On. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other defensive stocks billionaire Ken Fisher is betting on. Ken Fisher, an American billionaire investor, autho",
      "url": "https://finnhub.io/api/news?id=5a61632c3ef9b67852b1a7711606d09ff729b9975cd6925cae98ba75b3994261"
    },
    {
      "headline": "Johnson & Johnson (JNJ) Stock Moves -0.52%: What You Should Know",
      "source": "Yahoo",
      "datetime": 1744148716,
      "summary": "In the latest trading session, Johnson & Johnson (JNJ) closed at $149.83, marking a -0.52% move from the previous day.",
      "url": "https://finnhub.io/api/news?id=ad787759b84fc77476cdb04c6f417ab65449c9324249c4dd3831a4c7926d9e61"
    },
    {
      "headline": "Johnson & Johnson's New 'Compelling Data' Shows Sustained Symptom Improvement In Muscular Disease Patients",
      "source": "Yahoo",
      "datetime": 1744136792,
      "summary": "Johnson & Johnson (NYSE:JNJ) on Tuesday announced results from additional analyses of the Phase 3 Vivacity-MG3 study and the ongoing open-label extension (OLE), evaluating the long-term efficacy and safety of nipocalimab in a broad population of antibody-positive adults with generalized myasthenia g",
      "url": "https://finnhub.io/api/news?id=fdbcc6609708525d9145c5fa5b1c4c4d25fed64fa05f630967f397baf5264263"
    },
    {
      "headline": "Biopharma Shakeup: Goldman Boosts J&J, Eli Lilly While Flagging Risks at Pfizer and AbbVie",
      "source": "Yahoo",
      "datetime": 1744135093,
      "summary": "Goldman updates coverage across major U.S. drugmakers, citing exclusivity risks, pricing power, and pipeline outlooks",
      "url": "https://finnhub.io/api/news?id=bc94276900cad2ebcc0b80e6d2292450595274f18897df2b28b0da16be1a544f"
    },
    {
      "headline": "AAN 2025: J&J reveals data for nipocalimab, showing long-term disease control in MG",
      "source": "Yahoo",
      "datetime": 1744134280,
      "summary": "J&J exhibited additional findings from the Vivacity-MG3 study, displaying that nipocalimab met its key secondary endpoint.",
      "url": "https://finnhub.io/api/news?id=89f3d9fbbafc9265334924a2ea74638362c0539828fd0a90d48d44101500ac5c"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "8-K",
      "date": "2025-04-03",
      "description": "jnj-20250331.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000106/jnj-20250331.htm"
    },
    {
      "form": "4",
      "date": "2025-03-19",
      "description": "xslF345X05/wk-form4_1742429234.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000103/xslF345X05/wk-form4_1742429234.xml"
    },
    {
      "form": "4",
      "date": "2025-03-06",
      "description": "xslF345X05/wk-form4_1741297319.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000095/xslF345X05/wk-form4_1741297319.xml"
    },
    {
      "form": "4",
      "date": "2025-03-06",
      "description": "xslF345X05/wk-form4_1741297124.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000093/xslF345X05/wk-form4_1741297124.xml"
    },
    {
      "form": "4",
      "date": "2025-02-26",
      "description": "xslF345X05/wk-form4_1740613359.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000086/xslF345X05/wk-form4_1740613359.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}